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ABsTRACT 
InTRODUCTIOn: in general practice many patients present with emotional symptoms. Both patients 
and physicians desire effective non-pharmacological treatments. 
AIM: To study the effectiveness of problem-solving treatment (PsT) delivered by trained general prac-
tice registrars (GP registrars) for patients with emotional symptoms. 
METHODs: in a controlled clinical trial we compared the effectiveness of PsT versus usual care for pa-
tients with emotional symptoms. dutch GP registrars provided either PsT or usual care, according to their 
own preference. Patients were included if they (a) had presented for three or more consultations with 
emotional symptoms in the past six months; and (b) scored four or more on the 12-item General Health 
questionnaire. Outcomes at three- and nine-month follow-up were standard measures of depression, 
anxiety and quality of life. 
REsULTs: Thirty-eight GP registrars provided PsT and included 98 patients; 43 provided usual care and 
included 104 patients. PsT patients improved significantly more than usual care patients: at nine-month 
follow-up, recovery rates for somatoform disorder and anxiety were higher in the PsT group (OR 6.50, 
p=0.01 respectively OR 11.25, p=0.03). PsT patients had improved significantly more on the domains 
social functioning, role limitation due to emotional problems and general health perception. 
DIsCUssIOn: Patients with emotional symptoms improved significantly more after PsT delivered by 
motivated GP registrars than after usual care by GP registrars. Further research, with randomisation of 
interested registrars or interested GPs, is needed.
KEYWORDs: Problem-solving treatment; emotional symptoms; mental health; general practice; GP 
registrars
Introduction
In general practice, many patients have emotional 
symptoms and/or psychosocial problems.1,2 Most 
patients are treated adequately, but in a minority 
of cases a pattern of recurrent or chronic symp-
toms develops with a negative impact on quality 
of life3 and frequent consultations.4 This makes 
diagnosis and treatment of emotional symptoms 
an important task in general practice. General 
practitioners (GPs) often prescribe medication, 
usually benzodiazepines or antidepressants,2 
but medication is not always appropriate. It has 
important side effects,5,6 patient adherence is 
low7 and the effectiveness of antidepressants is 
being disputed.8 Alternative approaches have 
to be considered. This looks attractive as most 
patients prefer non-pharmacological treatments.9 
Counselling is nearly always part of the treat-
ment in general practice10 and has the potential to 
strengthen patients’ self-management. However, 
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its content often varies and evidence for its long-
term effectiveness is weak.11
Problem-solving treatment (PST) might be an 
attractive option because of its structured ap-
proach with a focus on patient empowerment.12 
PST is a brief psychological intervention suitable 
for primary care, focusing on how to deal with 
every day problems. PST is effective in anxiety 
and depression, especially in major depression,12–16 
and there are indications that it is effective for 
unexplained physical symptoms17 and in palliative 
care.18 A recent Cochrane review recommended 
further research on the effectiveness of PST in 
patients with emotional symptoms, irrespective 
of whether these fulfil the criteria for DSM-IV 
disorders.19 
GPs and general practice registrars (GP regis-
trars) have both expressed the need for an ef-
fective psychological treatment they can deliver 
themselves to manage patients with emotional 
symptoms.20–22 Training GP registrars in PST 
could meet GPs’ need in an early career stage. 
A pilot study with 11 GP registrars showed 
that registrars can be trained successfully in 
PST, but the authors recommended further 
investigation with a larger sample of registrars 
and evaluation of patient outcomes.23 We aimed 
to study the effectiveness of PST delivered by 
trained GP registrars for patients with  emo-
tional symptoms. 
Methods
Design 
We compared, in a pragmatic, controlled clinical 
trial, the effectiveness of PST versus usual care 
for patients with emotional symptoms. PST and 
usual care were applied by GP registrars. 
Setting
The study took place in a Dutch three-year 
GP residency programme. From 2003 to 
2005 the residency programme scheduled the 
participation of all third-year registrars (81) 
in this study as part of the core programme. 
Registrars participated in two groups, PST and 
‘usual care’. Initially, we assigned registrars 
randomly to PST or usual care. We had to 
change this selection as registrars who were 
uncomfortable with PST did not include any 
patients. We allowed the next year group 
(2004–2005) to choose the strategy they were 
most comfortable with: PST (including train-
ing) or usual care. Our study received ethical 
approval from the Medical Ethical Committee 
of the Radboud University Nijmegen Medical 
Centre (reference number 2003/178).
Recruitment and selection criteria 
We asked registrars to recruit adult patients 
who presented emotional symptoms during 
their regular clinical work in their training 
practice. We asked each registrar to recruit four 
to six patients because this was regarded as the 
maximum feasible number within one year of 
residency. We defined emotional symptoms 
as subthreshold as well as formal disorders of 
depressed mood, anxiety or stress, and psy-
chosocial problems. Patients were included in 
the study if they (a) had presented emotional 
symptoms during three or more consultations 
in the past six months, and (b)  had a score of 
four or more on the 12-item General Health 
Questionnaire (GHQ-12).24 Exclusion criteria 
were (a) severe physical disease, (b) severe men-
tal morbidity (organic psychiatric disorder, sub-
stance misuse, active suicidal ideas), (c) current 
or recent (past year) psychiatric or psychological 
treatment or cognitive behavioural therapy, (d) 
insufficient mastery of the Dutch language. 
Figure 1. Problem-solving treatment (PST)
A brief psychological treatment with seven stages:
1. Explanation and rationale
2. Clarification and definition of the problems 
3. Establishing achievable goals
4. Generating solutions
5. selecting preferred solution
6. implementing solution
7. Evaluation of progress
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WHAT GAP THIs FILLs
What we already know: in general practice many patients have emo-
tional symptoms and/or psychosocial problems. Both patients and general 
practice registrars (GP registrars) desire effective psychological treatments 
within primary care. 
What this study adds: Patients with emotional symptoms improved sig-
nificantly more after problem-solving treatment (PsT) delivered by motivated 
GP registrars than after usual care by GP registrars. PsT might be a practical 
vehicle for registrars to incorporate non-specific treatment skills more mani-
festly in their patient contacts.
Registrars received the support of a research 
assistant in the selection of suitable patients. All 
participating patients signed informed consent. 
Treatment and training
PST is a brief psychological treatment, derived 
from cognitive behavioural therapy, teaching 
patients how to use their own skills to cope with 
everyday life problems in a systematic way. It is 
assumed that symptoms reduce if control over 
problems is (re)gained.12 PST comprises seven 
stages (Figure 1). The treatment consists of four 
to six consultations over a period of approxi-
mately eight to 12 weeks with a duration of no 
more than 30 minutes, except for the first session 
which may last 60 minutes. 
The registrars were trained by experienced PST 
trainers in a two-day course, followed by super-
vised treatment and feedback meetings. Trainers 
assessed the quality of PST through registrars’ 
PST worksheets. Details about the feasibility of 
this training programme during residency were 
published before.25 The exact nature of ‘usual 
care’ was retrieved from patient records after 
the trial. Both treatment groups were allowed to 
prescribe medication. 
Follow-up and outcomes 
Primary outcomes were the proportion of patients 
who remitted, the reduction of symptoms, and 
improvement of quality of life. We used the Pri-
mary Health Questionnaire (PHQ) assessing the 
presence of  five DSM-IV disorders,26 the Hos-
pital Anxiety and Depression Scale (HADS),27 
the 36-item MOS short form (SF-36)28 and the 
5-dimension EuroQol measuring quality of life 
(EQ-5D),29 and the Social Problem-Solving (skills) 
Inventory—Revised measuring problem-solving 
skills (SPSI–R).30 Secondary outcomes were: pa-
tient satisfaction (a self-developed questionnaire 
based on the Consultation Satisfaction Question-
naire31 with nine items measuring satisfaction 
with the doctor and seven items measuring satis-
faction with the treatment); number of disability 
days;32 and health care utilisation. Health care 
utilisation data were collected from the patients’ 
records: data on referrals and medication, and 
numbers of contacts with the GP. Higher scale 
scores indicate better patient outcomes, except for 
the PHQ and HADS, where lower scores indicate 
better outcomes. 
Participants received self-completing question-
naires at baseline (T0), after treatment (at three 
months, T1) and at nine-month follow-up (T2). 
Record data of the six-month period before treat-
ment were compared to data of the six-month 
period after treatment. 
Sample size 
We aimed to detect a clinically relevant differ-
ence of 30% between interventions with the pri-
mary outcome measure PHQ. To provide a power 
of 80% at a two-sided 5% level of significance, we 
needed 42 patients with full data in each group. 
Analysis of effectiveness 
We conducted statistical analyses using the 
statistical software SPSS version 16.0, according 
to the intention-to-treat principle. We analysed 
all cases with data at baseline and data at T1 
and/or T2. We compared differences within the 
treatment groups with McNemar tests and paired 
t-tests to assess changes over time. In order to 
investigate the effect of the intervention, we 
used univariate general linear models and binary 
logistic regression using gender, age and baseline 
values as covariates to correct for baseline differ-
ences between treatment groups. We separately 
analysed the effect of treatment at T1 and T2. 
The effect of the intervention was the difference 
in outcome between the PST group and the usual 
care group (level of significance p<0.05). 
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Results 
Recruitment and follow-up
Thirty-eight registrars (28 women) provided PST 
and 43 (29 women) provided usual care. They 
included 202 patients: 98 in the PST group and 
104 in the usual care group (Figure 2). Patients 
in the PST group were significantly younger and 
more often female, had, at baseline, significantly 
higher symptom severity and significantly worse 
SPSI-scores than patients in the control group 
(Table 1). Overall, 128 (63%) participants returned 
follow-up questionnaires at T1 and 123 (61%) 
at T2. Patients lost to follow-up did not differ 
significantly from those who completed the study 
with regard to age, gender, PST or usual care, or 
baseline values. Medical records were retrieved 
for 96 PST patients and 99 control group patients 
(one patient died and six patients moved). 
Clinical outcome and quality of life
Both treatment groups improved significantly over 
time. Tables 2 and 3 show the results at T1 and T2 
compared to T0. From the PHQ we analysed the 
three most prevalent disorders: major depression 
(n=62), somatoform disorder (n=68), and other 
anxiety syndrome (n=50) (Table 1). The PST group 
showed significantly better recovery rates for 
somatoform disorder at T1 and T2 and for anxiety 
at T2, but not for major depression (Table 2). The 
HADS depression score improved significantly 
more in the PST group than in the usual care 
group at T1; the HADS anxiety score did so at T1 
and T2. In the PST group general health percep-
tion improved significantly more at T1 and T2. In 
Table 3 we present the three SF-36 domains most 
relevant to a mental health–oriented intervention: 
social function and mental role limitation im-
proved significantly more in the PST group at T2; 
mental health improved in both groups but did 
not differ significantly between groups at T1 nor 
T2. The EQ-5D scale improved more in the PST 
group at T1. Regarding problem-solving skills, 
the SPSI–R total scores did not show significant 
differences in change between groups.
There were no significant differences between 
patients recruited during the first year and the 
second year when the randomisation was released. 
Health care utilisation and disability days 
The numbers of patients being referred or using 
psychotropic medication during treatment did not 
differ significantly between groups. The changes 
in consultation rate and numbers of patients be-
ing referred or using psychotropic medication in 
the six months before versus the six months after 
treatment were not significantly different from 
usual care, but all in favour of PST. Absence 
from work did not differ significantly. 
Patient satisfaction
No significant differences in patient satisfac-
tion were found. At T1, PST patients scored 25.7 
(SD 5.0) and usual care patients 24.8 (SD 5.8) on 
the 45-point ‘satisfaction with physician’ scale 
and 20.5 (SD 4.3) and 19.4 (SD 4.6) respectively 
on the 35-point ‘satisfaction with treatment’ scale.
Treatment received
Patients in the intervention group received on 
average 4.3 PST sessions (range 1–7), including 
the consultation of study inclusion accompanied 
by the intake of PST. Fifty-three patients com-
Figure 2. Flow chart PST-trial
202 patients met entry criteria
98 patients assigned 
to receive PsT
104 patients assigned 
to receive usual care
92 responders 
at baseline
86 responders 
at baseline
63 responders at 10-week  
follow-up (64%)
60 responders at 36-week
follow-up (61%)
65 responders at 10-week  
follow-up (63%)
63 responders at 36-week
follow-up (61%)
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Table 1. Baseline characteristics
PST Usual care p-value
Patient characteristics (n=98) (n=104)
Mean age, years (sD) 40.3 (13.3) 46.0 (16.3) 0.01
Female, no. (%) 79/98 (81%) 63/104 (61%) <0.001
Married or living with partner, no. (%) 62/92 (67%) 51/79 (65%) 0.98
Ethnicity, European, no. (%) 83/91 (91%) 95/98 (97%) 0.09
Paid employment, no. (%) 61/92 (66%) 51/86 (59%) 0.33
Clinical characteristics (n=92) (n=86)
GHQ-12, mean (sD) 9.30 (2.37) 7.58 (2.56) <0.001
PHQ somatoform disorder, no. (%) 37 (40%) 31 (36%) 0.57
PHQ major depressive syndrome, no. (%) 37 (40%) 25 (29%) 0.12
PHQ other anxiety syndrome, no. (%) 32 (35%) 18 (21%) 0.04
HADs depression score, mean (sD) 9.26 (4.25) 8.09 (4.60) 0.05
HADs anxiety score, mean (sD) 10.41 (3.28) 9.14 (4.81) 0.08
sF-36 social functioning, mean (sD) 47.64 (19.20) 51.49 (23.85) 0.29
sF-36 mental health, mean (sD) 43.51 (13.56) 49.18 (20.28) 0.05
sF-36 role limitation due to emotional problems, mean (sD) 24.20 (30.05) 46.48 (41.59) <0.001
sF-36 general health perception, mean (sD) 55.12 (19.45) 55.68 (19.94) 0.87
EQ-5D score, mean (sD) 0.69 (0.16) 0.71 (0.19) 0.60
sPsI-R total score, mean (sD) 9.07 (2.64) 9.91 (2.72) 0.04
Table 2. Numbers of cases at Patient Health Questionnaire (PHQ) at three-month follow-up (T1) and nine-month follow-
up (T2) and binary logistic regression for differences in effects  between PST and usual care at T1 and T2 compared to 
baseline (with gender, age and baseline values as covariates)
Outcome
No of cases (%) Odds ratio (95% CI) for 
achievement of remission PST Usual care
PHQ somatoform disorder
T0 37/92 (40.2%) 31/86 (36.0%) ref
T1 6/63 (9.5%) 20/65 (30.8%) 6.52 (1.94 to 21.91)*
T2 4/60 (6.7%) 16/63 (25.4%) 6.50 (1.74 to 24.31)*
PHQ major depressive syndrome
T0 37/92 (40.2%) 25/86 (29.1%) ref
T1 8/63 (12.7%) 11/65 (16.9%) 1.90 (0.61 to 5.92)*
T2 5/60 (8.3%) 4/63 (6.3%) 0.62 (0.14 to 2.76)*
PHQ other anxiety syndrome
T0 32/92 (34.8%) 18/86 (20.9%) ref
T1 6/63 (9.5%) 8/65 (12.3%) 2.02 (0.56 to 7.31)*
T2 1/60 (1.7%) 7/63 (11.1%) 11.25 (1.21 to 104.26)*
PsT = problem-solving treatment
Ci = confidence interval
ref = reference group
* adjusted for gender, age and baseline values
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Table 3. Mean scores on main outcome scales at three-month follow-up (T1) and nine-month follow-up (T2) and ANCOVA 
for differences in effects over time between PST and usual care (with gender, age and baseline values as covariates)
 Outcome*
Mean score (SD)
Mean difference (95% CI) 
between PST and usual care
PST† Usual care† B-coefficient
HADs
Depression score 
T0 9.26 (4.25) 8.09 (4.60) ref
T1 4.97 (4.12) 6.73 (4.40) -1.88 (-3.11 to -0.64)‡
T2 4.55 (4.45) 5.47 (3.65) -1.23 (-2.49 to 0.02)‡
Anxiety score
T0 10.41 (3.28) 9.14 (4.81) ref
T1 6.98 (3.94) 8.33 (4.80) -2.17 (-3.44 to -0.90)‡
T2 6.65 (3.25) 7.05 (4.93) -1.33 (-2.50 to -0.15)‡
sF-36 
social functioning
T0 47.64 (19.20) 51.49 (23.85) ref
T1 65.97 (23.42) 57.33 (25.73) 5.81 (-3.73 to 15.36)‡
T2 73.23 (18.30) 62.80 (23.45) 9.83 (1.27 to 18.39)‡
Mental health
T0 43.51 (13.56) 49.18 (20.28) ref
T1 64.25 (18.16) 61.36 (21.37) 3.69 (-3.13 to 10.51)‡
T2 68.00 (17.06) 66.26 (18.64) 4.49 (-2.13 to 11.12)‡
Role limitation due to emotional problems
T0 24.20 (30.05) 46.48 (41.59) ref
T1 63.89 (42.85) 56.67 (44.80) 9.58 (-8.44 to 27.60)‡
T2 80.30 (36.17) 70.29 (42.30) 17.18 (0.69 to 33.67)‡
General health perception
T0 55.12 (19.45) 55.68 (19.94) ref
T1 64.69 (22.99) 57.94 (19.98) 8.00 (1.81 to 14.20)‡
T2 70.39 (19.48) 61.48 (20.27) 10.48 (3.66 to 17.30)‡
EQ-5D
T0 0.69 (0.16) 0.71 (0.19) ref
T1 0.81 (0.17) 0.71 (0.16) 0.09 (0.03 to 0.14)‡
T2 0.82 (0.18) 0.79 (0.14) 0.02 (-0.03 to 0.07)‡
sPsI–R 
T0 9.07 (2.64) 9.91 (2.72) ref
T1 9.98 (2.68) 10.57 (2.49) -0.49 (-1.20 to 0.21)‡
T2 10.13 (2.58) 10.86 (2.52) -0.13 (-0.87 to 0.60)‡
PsT = problem-solving treatment
sd = standard deviation
Ci = confidence interval
* HAds = 21-point scales
 sF-36 = 100-point scales
 Eq-5d = 1-point scale
 sPsi-R = 20-point scale
† PsT group: at T0 n=92; at T1 n=63 ; at T2 n=60. Usual care group: at T0 n=86; at T1 n=65; at T2 n=63.
‡ Adjusted for gender, age and baseline values
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pleted treatment (≥ 4 sessions) with on average 
5.3 sessions (range 4–7). The mean number of 
consultations in addition to PST sessions during 
the three-month treatment period was 0.7 (range 
0–5). Based on worksheets of PST sessions the 
PST supervisor reported good quality perform-
ance of PST.
In the usual care group, the average number 
of consultations—for any reason—during the 
three-month treatment period was 3.3 (range 
1–12). Most registrars used counselling in most 
consultations, but content and duration were not 
described in the records. 
Discussion
Both PST and usual care patients with emo-
tional symptoms improved significantly over 
time. However, patients who were treated by 
GP registrars providing PST had significant 
better outcomes than patients who were treated 
significant differences in favour of PST were 
found on the HADS concerning the severity of 
anxiety and depressive symptoms. Thus, PST 
did not diminish the number of cases of depres-
sion, but reduced symptom severity. Strikingly, 
SPSI scores did not differ significantly between 
groups. This could be due to the fact that actual 
problem-solving performance is not necessarily a 
function of cognitive-behavioural skills in gener-
ating solutions.33 
Strengths and limitations of the study 
Notwithstanding these positive findings, 
this study has limitations. Firstly, the lack of 
randomisation of registrars providing PST. The 
registrars who were initially randomised to PST 
and were uncomfortable with it, did not recruit 
patients, not allowing any comparison. Changing 
the selection of registrars by offering the choice 
between PST and usual care may have resulted 
in potentially overestimating the impact of 
Both PST and usual care patients with emotional symptoms improved 
significantly over time. However, patients who were treated by GP 
registrars providing PST had significant better outcomes than 
patients who were treated by registrars providing usual care.
by registrars providing usual care. PST patients 
reported significantly fewer symptoms of de-
pression and anxiety, and a significantly higher 
general health perception than usual care patients 
did, both short- and long-term. PST patients had 
a significantly higher chance of recovery from 
somatoform disorder short-term. Long-term this 
was also the case for anxiety. Long-term they 
reported significantly better scores of social 
function and role limitation due to emotional 
problems, corresponding with a relevantly better 
subjective function in daily life. This fits in with 
earlier research that found significantly better 
improvements of quality of life after PST than 
after usual care.14
The PHQ did not show significant differences 
in recoveries of major depressive disorder, but 
PST, because PST registrars were probably more 
motivated to deliver mental health care than 
their usual care colleagues. However, there were 
no differences in outcome between patients of 
registrars randomly allocated to PST and patients 
of registrars who made a choice for it. Also, reg-
istrars in the usual care group were not necessar-
ily unmotivated for mental health care: probably 
they did not perceive the need for more training, 
because they felt at ease using the prevailing 
Dutch College guidelines of depression and anxi-
ety.34,35 Furthermore, patient satisfaction with 
their GP registrar treatment was not significantly 
different between treatment groups. 
The second limitation was the limited comple-
tion of follow-up measures, although this is 
common in trials with psychological interven-
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tions.36 The third limitation was the selection 
of patients, with registrars in the intervention 
group selecting patients mainly themselves. Reg-
istrars in the usual care group partly did so, but 
to reach the numbers planned in advance, had to 
be assisted by a research assistant. PST registrars 
enrolled patients they thought would benefit 
from PST. Although this reflected daily prac-
tice in the sense that GPs offer only treatments 
to patients when they expect a positive effect, 
it resulted in a biased selection of patients: all 
patients met the eligibility criteria of ‘emo-
tional symptoms’, a consultation rate of three or 
more, and a GHQ-12 score of four or more, but 
PST patients were more often female, younger 
and had more severe psychological symptoms. 
Patients in the PST group might have been more 
suitable and more motivated for treatment than 
usual care patients. This limitation also might 
have overestimated treatment effects of PST. 
Although we corrected for the baseline differ-
ences in our analyses and still found significant 
advantages of PST above usual care, this limi-
tation—together with the lack of randomisation 
of registrars—compromises the internal validity. 
Also, through the lack of randomisation of both 
registrars and patients, this study—originally 
designed and started as a randomised controlled 
trial—could in the end be regarded as two case 
series with one series of patients treated with 
PST and another with usual care. 
Due to the compromised internal validity, it 
remains unclear whether the effects were the re-
sults of (a) specific PST techniques, (b) motivated 
registrars, (c) more open attitudes of PST patients 
towards treatment, or (d) a treatment like PST as 
a vehicle for registrars to incorporate non-specific 
skills—such as empathy, warmth and the doctor–
patient relationship—better into their consulta-
tions with patients with emotional problems. The 
last option might be realistic, because a focus 
group study showed that registrars expressed that 
they implemented many new skills during PST.37 
The registrars mentioned, for instance, that 
they appreciated the patient-centred and patient-
empowering character, including the activation 
of patients to implement their own solutions 
in daily life. In earlier research, Australian 
GPs mentioned these elements too.38 Therefore, 
we think that a treatment like PST might be a 
practical vehicle for registrars to incorporate non-
specific treatment skills more manifestly in their 
patient contacts. 
A strength of our study is that, to our knowl-
edge, this was the first study with PST being 
provided by physicians from the patients’ own 
general practice. All other PST studies involved 
PST therapists who were unknown to the 
patient whereas usual care was delivered by the 
patient’s own GP. This probably overestimated 
usual care effects in earlier studies because the 
doctor–patient relationship influences patient 
outcome importantly.39 Another strength is that 
this study was one of the very few studies 
with GP registrars providing a specific psy-
chological treatment for emotional symptoms, 
including measurement of patient outcomes. 
Recent Chinese research with registrars provid-
ing PST voluntarily did not show significant 
benefit of PST over placebo group intervention. 
These registrars, however, only provided three 
sessions of PST.40 
We recommend a trial with randomisation of 
registrars who are interested in providing PST. In 
this trial, measurement of motivation must be part 
of the design. Furthermore, we suggest investigat-
ing the effectiveness of PST when provided by the 
patient’s own GP, because effects build upon the 
more longstanding relationship with the patient. 
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